New Monoclonal Antibody Characterization Platform Analyzes over 1000 Samples Per Day

Dionex, the leader in monoclonal antibody analysis solutions, is pleased to announce the release of a new Dionex Monoclonal Antibody (MAb) Characterization Platform, built on the proven Dionex UltiMate® 3000 HPLC system. With an increasing demand for newer and better MAb candidates, there is a bottleneck in the MAb characterization process which is addressed by the Dionex MAb platform.

The Dionex MAb Characterization Platform automates the three manual steps required in the screening and analysis of MAbs, and thus speeds up product development by increasing sample throughput. The fully biocompatible platform features a dual ternary gradient pump design and an integrated fraction collector with the ability to automatically re-inject samples into the second dimension.

Applications that could benefit from these features include automation of purification and analysis of hundreds of MAb samples.

The off-line column regeneration feature in tandem configuration allows the analysis of over 1000 MAb samples a day while the dual column option in parallel configuration allows multiple analyses to be performed on the same sample simultaneously.

New columns for this platform include:
• MabPac™ SCX-10 cation exchange columns for the high resolution and characterization of MAb variants plus new three new column formats: 4 × 150 mm for fast MAb separations; 4 × 50 mm column for pH gradients; and 2 × 150 mm for upstream separations in LC/MS applications.
• MAbPac SEC-1 size exclusion chromatography columns for the separation and analysis of MAbs, their aggregates, and fragments.

For more information, visit the company article page.